CureSearch Research Programs: information for Applicants
In order to ensure that CureSearch funds the best science with the greatest potential to reach pediatric cancer patients in an accelerated time-frame, CureSearch employs a rigorous review process that engages members throughout the drug development ecosystem. Input of scientists, oncologists, and industry experts enables CureSearch to support projects that are positioned to succeed.
CureSearch application submissions and reviews follow a two-stage process. Applicants first must submit a “Letter of Intent” (LOI). LOIs are administratively reviewed by CureSearch Scientific Staff and then reviewed by the CureSearch Scientific Review Committee (SRC). Top scoring LOIs are invited to submit full proposals, which elaborate on the projects initially outlined in the LOI.
CureSearch Grant Cycle Timeline
RFAs are posted in ProposalCentral annually, according to the below timeline.
|Request for Applications Opens||Early June|
|Letter of Intent Deadline||Mid-June|
|LOI Notification/Full Applications Invited||Early September|
|Full Applications Due||Mid-October|
|Earliest Award Notification*||Early January|
Click here to add yourself to our mailing list and be the first to know about new RFAs.
Please email Holly Zink, Senior Director of Research and Programs, with any questions or comments.